BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 12568498)

  • 1. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of airway mucus hypersecretion.
    Rogers DF; Barnes PJ
    Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
    Disse B
    Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary mucus: Pediatric perspective.
    Rogers DF
    Pediatr Pulmonol; 2003 Sep; 36(3):178-88. PubMed ID: 12910578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
    Lai H; Rogers DF
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis.
    Simpson JL; Phipps S; Gibson PG
    Pharmacol Ther; 2009 Oct; 124(1):86-95. PubMed ID: 19555716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy.
    Lai HY; Rogers DF
    Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):67-76. PubMed ID: 19907312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
    Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
    Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway mucus hypersecretion in asthma: an undervalued pathology?
    Rogers DF
    Curr Opin Pharmacol; 2004 Jun; 4(3):241-50. PubMed ID: 15140415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options.
    Rogers DF
    COPD; 2005 Sep; 2(3):341-53. PubMed ID: 17146999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending the understanding of sensory neuropeptides.
    De Swert KO; Joos GF
    Eur J Pharmacol; 2006 Mar; 533(1-3):171-81. PubMed ID: 16464447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological studies in mucus hypersecretion.
    Vestbo J
    Novartis Found Symp; 2002; 248():3-12; discussion 12-9, 277-82. PubMed ID: 12568485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging mucus regulating drugs in inflammatory and allergic lung disease.
    Hauber HP; Zabel P
    Inflamm Allergy Drug Targets; 2008 Mar; 7(1):30-4. PubMed ID: 18473898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential therapeutic role of potassium channel modulators in asthma and chronic obstructive pulmonary disease.
    Malerba M; Radaeli A; Mancuso S; Polosa R
    J Biol Regul Homeost Agents; 2010; 24(2):123-30. PubMed ID: 20487625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches for inhibition of mucus hypersecretion in asthma.
    Agrawal A; Mabalirajan U; Ram A; Ghosh B
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):188-92. PubMed ID: 19075982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma.
    Singer M; Martin LD; Vargaftig BB; Park J; Gruber AD; Li Y; Adler KB
    Nat Med; 2004 Feb; 10(2):193-6. PubMed ID: 14716307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The airway pathophysiology of COPD: implications for treatment.
    Rodríguez-Roisin R
    COPD; 2005 Jun; 2(2):253-62. PubMed ID: 17136952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.